Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 02/05/2024
In
Objective
To generate long-term capital appreciation by investing in a globally diversified portfolio of healthcare companies, to include, but not limited to, pharmaceutical, biotechnology, medical device and healthcare services companies.
AIC sector
Management group
Polar Capital Holdings
Company website
Launch date
15/06/2010
September
Domicile
United Kingdom
Fund manager
David Pinniger, James Douglas, Deane Donnigan, Gareth Powell
Dividend frequency
Semi-Annually
Wind-up provisions
The Company does not have, and does not expect to have, any other business interests, and the current activities of the Company are expected to continue until the scheduled ZDP Repayment Date of 19 June 2024 at which time the Company will enter into voluntary liquidation.
508.13
| Share type | Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Share | 439.00 | 468.77 | 362.00 | 386.55 | -6.35 | 7 | 0.61 | Feb, Aug | 0.87 (30/09/2023) |
| Polar Capital Glb Healthcare ZDP 2024 | 38.88 | 39.36 | 121.00 | 122.51 | -1.23 | 0 | N/A | N/A | N/A |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-Dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 01/02/2024 | 29/02/2024 | 1.200 | No | 2023 |
| 03/08/2023 | 31/08/2023 | 1.000 | No | 2023 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Polar Capital Global Healthcare | Share price total return | 9.1 | 40.5 | 83.7 | 167.1 |
| Biotechnology & Healthcare AIC sector | Share price total return | N/A | N/A | N/A | N/A |
Scroll
Share structure
2,879,256
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 112,536 | 4,506,418 | 45,610,719 | 253,952,467 |
| Polar Capital Glb Healthcare Ord Average | N/A | 185,212 | 179,335 | 200,241 |
| Polar Capital Glb Healthcare ZDP 2024 Total | 0 | 112,301 | 1,712,298 | 8,062,116 |
| Polar Capital Glb Healthcare ZDP 2024 Average | N/A | 5,105 | 6,663 | 6,274 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 0.41 | 16.53 | 154.58 | 701.94 |
| Polar Capital Glb Healthcare Ord Average | N/A | 0.68 | 0.61 | 0.55 |
| Polar Capital Glb Healthcare ZDP 2024 Total | N/A | 0.14 | 2.01 | 9.07 |
| Polar Capital Glb Healthcare ZDP 2024 Average | N/A | 0.01 | 0.01 | 0.01 |
Scroll
Trading details
Top holdings
Data as at : 31/03/2024
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 8.5 |
| UnitedHealth Group Inc | 6.3 |
| Zealand Pharma A/S | 5.6 |
| AbbVie Inc | 5.6 |
| Intuitive Surgical Inc | 4.7 |
| Novartis AG Registered Shares | 4.5 |
| UCB SA | 4.1 |
| Sanofi SA | 3.9 |
| Elevance Health Inc | 3.6 |
| Becton Dickinson & Co | 3.5 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
